| |
| |
|
| Insider
Information: |
Mahony Susan |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
40,685 |
|
|
Indirect Shares
|
18,339 |
|
|
| Direct
Value |
$34,581,843 |
|
|
|
Indirect Value
|
$15,587,967 |
|
|
| Total
Shares |
59,024 |
|
|
| Total
Value |
$50,169,810 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
SVP & Pres., Lilly Onc... |
2018-04-16 |
40,685 |
2018-04-16 |
18,339 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
96,040 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-02-11 |
4 |
OE |
$56.18 |
$507,642 |
D/D |
9,036 |
95,793 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,591 |
93,408 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,843 |
91,524 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$352,027 |
D/D |
(4,570) |
91,470 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,107 |
89,425 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-02-11 |
4 |
D |
$70.50 |
$568,583 |
D/D |
(8,065) |
87,728 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-02-01 |
4 |
D |
$72.00 |
$426,312 |
D/D |
(5,921) |
87,487 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-02-01 |
4 |
D |
$79.10 |
$366,154 |
D/D |
(4,629) |
86,895 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-12-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
730 |
86,757 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-01-27 |
4 |
A |
$75.38 |
$1,450,537 |
D/D |
19,243 |
86,308 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-02-01 |
4 |
D |
$54.01 |
$357,924 |
D/D |
(6,627) |
82,798 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-01-26 |
4 |
A |
$81.96 |
$1,564,862 |
D/D |
19,093 |
81,681 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-01-28 |
4 |
A |
$70.97 |
$1,936,558 |
D/D |
27,287 |
80,817 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-01-28 |
4 |
A |
$54.23 |
$1,588,288 |
D/D |
29,288 |
75,318 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-12-16 |
4 |
S |
$72.65 |
$1,387,106 |
D/D |
(19,093) |
67,802 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
737 |
67,065 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-07-28 |
4 |
S |
$84.96 |
$2,124,000 |
D/D |
(25,000) |
62,728 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-03-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
140 |
62,588 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-08-13 |
4 |
OE |
$55.65 |
$474,194 |
D/D |
8,521 |
61,319 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,326 |
60,350 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,943 |
57,380 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-12-04 |
4 |
AS |
$86.18 |
$3,152,895 |
D/D |
(36,585) |
54,885 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-08-13 |
4 |
D |
$60.88 |
$474,194 |
D/D |
(7,789) |
53,530 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-07-25 |
4 |
S |
$63.90 |
$1,917,000 |
D/D |
(30,000) |
52,798 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
